entertainment -WSS

entertainment

author：focus 2025-09-27 21:54:46 - browse：83

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Flint parents haunted by uncertainty, fears of lead poisoning

WSS

Heart disease in astronauts blamed on cosmic radiation

CDC recommends RSV monoclonal antibody for infants

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Florida officials tell state schools to teach AP Psychology 'in its entirety'

2 officers injured in shooting in Orlando, police say

knowledge

entertainment

entertainment

Hollywood unions extend contract negotiations for actors

Readout Newsletter: CAR

After affirmative action ruling, medical educators look to 'holistic review'

Physicians aren't 'burning out.' They're suffering from moral injury

Duchenne breakthrough therapy leaves behind pioneering families

RaDonda Vaught links Vanderbilt hospital issues to patient death

Wildfire smoke exposes gaps in outdoor worker protections

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Heart attack and stroke risk calculators need revising

Change Healthcare outage fallout shows need for new oversight

entertainment

UCLA team creates talking throat patch for voice disorders

Heart disease in astronauts blamed on cosmic radiation

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Pushing for an NIH office for post

leisure time

focus

explore

hotspot